|
Volumn 19, Issue 2, 2001, Pages 341-346
|
Changes in intratumoral thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) mRNA expression in colorectal and gastric cancer during continuous tegafur infusion.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
DIHYDROPYRIMIDINE DEHYDROGENASE;
MESSENGER RNA;
OXIDOREDUCTASE;
TEGAFUR;
THYMIDYLATE SYNTHASE;
ARTICLE;
CLINICAL TRIAL;
COLORECTAL TUMOR;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE FREE SURVIVAL;
DRUG EFFECT;
FEMALE;
GENE EXPRESSION REGULATION;
GENETICS;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
METABOLISM;
MIDDLE AGED;
PATHOLOGY;
RANDOMIZED CONTROLLED TRIAL;
STOMACH TUMOR;
TIME;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
COLORECTAL NEOPLASMS;
DIHYDROURACIL DEHYDROGENASE (NADP);
DISEASE-FREE SURVIVAL;
FEMALE;
GENE EXPRESSION REGULATION, ENZYMOLOGIC;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
INFUSIONS, INTRAVENOUS;
MALE;
MIDDLE AGED;
OXIDOREDUCTASES;
RNA, MESSENGER;
STOMACH NEOPLASMS;
TEGAFUR;
THYMIDYLATE SYNTHASE;
TIME FACTORS;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 0035430619
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.19.2.341 Document Type: Article |
Times cited : (27)
|
References (0)
|